Colgate-Palmolive Company

NYSE:CL Stok Raporu

Piyasa değeri: US$76.3b

Colgate-Palmolive Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Colgate-Palmolive is forecast to grow earnings and revenue by 6.7% and 3.6% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 183.2% in 3 years.

Anahtar bilgiler

6.7%

Kazanç büyüme oranı

7.8%

EPS büyüme oranı

Household Products kazanç büyümesi8.0%
Gelir büyüme oranı3.6%
Gelecekteki özkaynak getirisi183.2%
Analist kapsamı

Good

Son güncelleme02 Nov 2024

Gelecekteki son büyüme güncellemeleri

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Recent updates

If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity

Oct 26
If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity

Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now

Oct 25

Colgate-Palmolive: Very Close To A Buy Following Recent Pullback

Oct 17

Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)

Sep 30

These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well

Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down

Aug 27
Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Jul 11
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Jul 10

Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite

Jun 23

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Jun 06
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

May 21
Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Colgate-Palmolive: Loading Up Ahead Of Earnings

Apr 16

Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Apr 02
Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 18
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Feb 14
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Colgate-Palmolive: I'm Buying Before Interest Rates Decrease

Feb 14

Colgate-Palmolive: Brushing Up Profits In Q4 2023

Jan 30

Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Jan 19
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Jan 01
Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)

Dec 20

Colgate-Palmolive Stock And Its Real Value

Nov 29

Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On

Nov 14

Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Nov 06
Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Colgate-Palmolive: Own This Dividend King At The Right Price

Oct 31

Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now

Oct 13

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Oct 02
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive: Dividend King With Limited Growth

Sep 27

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Colgate-Palmolive: Improving Prospects And A Reasonable Valuation

Sep 09

Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World

Aug 16

Colgate And The Importance Of Sales Growth, Expectations Matter

Aug 09

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Aug 03
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive: Challenging Growth Prospects

Jul 10

Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Jun 27
Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Jun 13
Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Colgate-Palmolive: The Reasons We Are Becoming More Cautious

Jun 05

Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Jun 05
Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Kazanç ve Gelir Büyüme Tahminleri

NYSE:CL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202621,7333,4253,6664,28715
12/31/202520,8513,1483,4414,03520
12/31/202420,1992,9093,4253,84519
9/30/202420,1062,8683,4003,974N/A
6/30/202419,9892,8403,3583,959N/A
3/31/202419,7522,6113,0233,691N/A
12/31/202319,4572,3003,0403,745N/A
9/30/202319,1361,5872,5533,282N/A
6/30/202318,6761,4972,3563,099N/A
3/31/202318,3381,5982,1682,905N/A
12/31/202217,9671,7851,8602,556N/A
9/30/202217,7411,9282,3212,989N/A
6/30/202217,7001,9442,3843,014N/A
3/31/202217,4762,0442,5313,113N/A
12/31/202117,4212,1662,7583,325N/A
9/30/202117,3422,6652,6473,182N/A
6/30/202117,0812,7292,6623,150N/A
3/31/202116,7182,6613,1143,549N/A
12/31/202016,4712,6953,3093,719N/A
9/30/202016,1622,6913,3683,726N/A
6/30/202015,9372,5713,3303,678N/A
3/31/202015,9062,5222,9503,296N/A
12/31/201915,6932,3672,7983,133N/A
9/30/201915,4892,3302,6843,025N/A
6/30/201915,4062,2752,6423,008N/A
3/31/201915,4262,3262,6563,045N/A
12/31/201815,5442,4002,6203,056N/A
9/30/201815,6252,1172,4612,953N/A
6/30/201815,7542,201N/A3,046N/A
3/31/201815,6942,088N/A2,979N/A
12/31/201715,4542,024N/A3,054N/A
9/30/201715,2832,307N/A3,119N/A
6/30/201715,1762,402N/A3,126N/A
3/31/201715,1952,478N/A3,218N/A
12/31/201615,1952,441N/A3,141N/A
9/30/201615,3732,461N/A3,158N/A
6/30/201615,5052,485N/A3,046N/A
3/31/201615,7262,459N/A2,836N/A
12/31/201516,0342,468N/A2,949N/A
9/30/201516,3562,470N/A3,014N/A
6/30/201516,7362,286N/A3,132N/A
3/31/201517,0222,334N/A3,205N/A
12/31/201417,2772,180N/A3,298N/A
9/30/201417,4172,116N/A3,231N/A
6/30/201417,4362,230N/A3,268N/A
3/31/201417,4302,169N/A3,247N/A
12/31/201317,4202,241N/A3,204N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CL's forecast earnings growth (6.7% per year) is above the savings rate (2.5%).

Kazançlar ve Piyasa: CL's earnings (6.7% per year) are forecast to grow slower than the US market (15.4% per year).

Yüksek Büyüme Kazançları: CL's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: CL's revenue (3.6% per year) is forecast to grow slower than the US market (8.9% per year).

Yüksek Büyüme Geliri: CL's revenue (3.6% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CL's Return on Equity is forecast to be very high in 3 years time (183.2%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y